Cart (0)
Your shopping cart is empty!
Biosib.com
Klebsiella purified polyvalent bacteriophage , bottles of 20 ml, 4 pcs.
Klebsiella purified polyvalent bacteriophage , bottles of 20 ml, 4 pcs.
Product Code: klebsiella-puri-poly-phage-4x20

Klebsiella purified polyvalent bacteriophage , bottles of 20 ml, 4 pcs.

Compare this Product
$26.00
Out Of Stock

Klebsiella purified polyvalent bacteriophage , bottles of 20 ml, 4 pcs.


Presentation


Solution for oral, local and external administration, 10 ml or 20 ml vials. 4 or 10 vials in each cardboard package with a package insert. 4 vials in each PVC blister. 1 PVC blister in each cardboard package with a package insert.


Ingredients

The preparation is a sterile mixture of purified filtrates of phage lysates of Klebsiella pneumoniae, Klebsiella ozaenae, Klebsiella rhinoscleromatis.


Excipient:

preservative – 8-hydroxyquinoline sulfate monohydrate - 0.0001 g/ml (equal to 8-hydroxyquinoline sulfate, estimated content).

Indications

Treatment and prevention of diseases caused by Klebsiella pneumoniae, Klebsiella ozaenae, Klebsiella rhinoscleromatis as part of the complex therapy:

  • atrophic rhinitis, scleroma;
  • disease of the gastrointestinal tract (gastroenterocolitis, cholecystitis, pancreatitis, intestinal disbacteriosis);
  • inflammatory diseases of infants and young children (gastroenterocolitis, intestinal disbacteriosis, omphalitis, pemphigus, pyoderma, septicemia and pyosepticemia of varios localization);
  • surgical infections (festering wounds, purulent skin lesions, burns, peritonitis, pleurisy, mastitis, osteomyelitis, abscess);
  • urogenital infections (cystitis, pyelonephritis, urethritis, endometritis, vulvitis, bartholinitis, colpitis, salpingo-oophoritis);
  • purulent-inflammatory diseases of the ear, nose, sinuses, oral cavity, pharynx, larynx, bronchi, lungs and pleura (otitis, tonsillitis, pharyngitis, laryngitis, stomatitis, periodontal disease, sinusitis, sinusitis, bronchitis, pneumonia, pleurisy);
  • post-traumatic conjunctivitis, keratoconjunctivitis, corneal ulcers and purulent iridocyclitis;
  • prevention of hospital-acquired infections caused by Klebsiella.


An important condition for the effective phage therapy is a preliminary determination of the phage sensitivity of the pathogen.